| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |